DAVID NIELSEN to Substance-Related Disorders
This is a "connection" page, showing publications DAVID NIELSEN has written about Substance-Related Disorders.
Connection Strength
1.733
-
Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system. Psychiatr Genet. 2015 Oct; 25(5):181-93.
Score: 0.364
-
Serotonergic gene variation in substance use pharmacotherapy: a systematic review. Pharmacogenomics. 2015; 16(11):1307-14.
Score: 0.361
-
Pharmacogenetics of addiction therapy. Methods Mol Biol. 2014; 1175:589-624.
Score: 0.323
-
Epigenetics of drug abuse: predisposition or response. Pharmacogenomics. 2012 Jul; 13(10):1149-60.
Score: 0.291
-
Correlates of Risk for Disinhibited Behaviors in the Million Veteran Program Cohort. JAMA Psychiatry. 2024 Feb 01; 81(2):188-197.
Score: 0.162
-
Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders. Pharmacogenet Genomics. 2015 Jun; 25(6):296-304.
Score: 0.089
-
Bidirectional translational research: Progress in understanding addictive diseases. Neuropharmacology. 2009; 56 Suppl 1:32-43.
Score: 0.056
-
Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci. 2005 Nov; 8(11):1450-7.
Score: 0.046
-
Genes associated with addiction: alcoholism, opiate, and cocaine addiction. Neuromolecular Med. 2004; 5(1):85-108.
Score: 0.040